Understanding Lichen Planus: Pathogenesis and Treatment Options

Lichen planus is a chronic inflammatory skin condition that affects approximately 1.5% of the population. It is characterized by pruritic, polygonal, purplish papules and plaques that can occur on various body sites, including the skin, oral mucosa, and nails. Understanding its pathogenesis and treatment options is essential for dermatologists and healthcare professionals managing patients with this condition.Pathogenesis of Lichen PlanusThe precise etiology of lichen planus remains unclear, but it is considered an autoimmune disorder. The immune system mistakenly targets the basal layer of the epidermis, leading to inflammatory changes.Genetic and Environmental FactorsThere is evidence suggesting a genetic predisposition to lichen planus, with certain HLA associations noted in affected individuals. Additionally, environmental triggers such as medications (e.g., nonsteroidal anti-inflammatory drugs, antihypertensives), viral infections (notably hepatitis C), and stress have been implicated in the development of the disease. These factors may initiate or exacerbate the immune response, leading to the characteristic lesions.Histological FeaturesHistological examination typically reveals a band-like infiltrate of lymphocytes at the dermal-epidermal junction, along with liquefactive degeneration of the basal cell layer. These findings are crucial for differentiating lichen planus from other dermatological conditions, such as psoriasis or contact dermatitis.Treatment Options for Lichen PlanusManagement of lichen planus can be challenging and varies depending on the extent of the disease and patient symptoms. The primary goals of treatment are to alleviate symptoms, improve appearance, and prevent relapse.Topical TherapiesFor localized cases, topical corticosteroids are the first-line treatment. High-potency corticosteroids can help reduce inflammation and pruritus, promoting healing of lesions. Other topical agents include:Calcineurin inhibitors (e.g., tacrolimus) – part